Barclays’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-180
| Closed | -$2K | – | 4588 |
|
|
2023
Q1 | $2K | Hold |
180
| – | – | ﹤0.01% | 4237 |
|
|
2022
Q4 | $1K | Hold |
180
| – | – | ﹤0.01% | 4352 |
|
|
2022
Q3 | $1K | Hold |
180
| – | – | ﹤0.01% | 4599 |
|
|
2022
Q2 | $2K | Sell |
180
-210
| -54% | -$2.33K | ﹤0.01% | 4598 |
|
|
2022
Q1 | $8K | Buy |
+390
| New | +$8K | ﹤0.01% | 4525 |
|